Jump Financial’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$83.6K Sell
10,400
-7,669
-42% -$77.2K ﹤0.01% 2213
2026
Q2
$236K Buy
+18,069
New +$184K ﹤0.01% 1779

Other funds holding EIKN

Jump Financial's EIKN Position: Q3 2026 in Review

Jump Financial reduced its Eikon Therapeutics (EIKN) stake by 42% in Q3 2026, selling an estimated $77.2K and leaving 10,400 shares worth $83.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2213.

Jump Financial first reported a position in EIKN in Q2 2026 and has held it in 2 quarters since. The position peaked at $236K in Q2 2026. 98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • Jump Financial held 10,400 shares of Eikon Therapeutics worth $83.6K as of Q3 2026.
  • Jump Financial sold 7,669 Eikon Therapeutics shares in Q3 2026, an estimated $77.2K.
  • Eikon Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2213 holding.
  • Jump Financial first reported a position in Eikon Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Jump Financial's Eikon Therapeutics position peaked at $236K in Q2 2026.
  • 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.